Communication - IIS Aragón

30 December, 2024

A new drug improves clinical outcomes for patients with advanced breast cancer

A Phase 3 clinical trial demonstrates that the combination of imlunestrant and abemaciclib improves progression-free survival in advanced ER+ HER2- breast cancer, regardless of genomic profile. The compound as monotherapy only shows benefits in patients with mutations in the ESR1 gene.
27 December, 2024

A group of researchers develop an AI model to predict the risk of metabolic disorders in children with obesity

The system integrates epigenetic clinical data, allowing early detection and personalized prevention of metabolic complications, especially during puberty, a key stage to avoid future cardiovascular diseases.
26 December, 2024

A researcher from IIS Aragón chosen to represent women scientists in “Pioneers”

Rebeca Sanz, principal investigator of the Cancer Heterogeneity and Immunonomics group, is the star of the new edition of the Teruel Provincial Council calendar along with 11 other women from Bajo Aragón who are leaders in their fields.
24 December, 2024

The HUMS Urology Service has received two awards for its innovation and commitment to quality care in prostate cancer

Raquel Espílez and Ángel Borque, researchers at the IIS Aragón and specialists in the urology service at the Miguel Servet University Hospital, have received two important awards in the Third Call for Scholarships in Prostate Cancer Care Quality.
23 December, 2024

The Government of Aragon finances the hiring of 65 predoctoral researchers with 6,9 million euros

They will join the Aragon Health Research Institute (ISS Aragón), the University of Zaragoza, the Spanish National Research Council (CSIC) and the San Jorge University Foundation. 70% of the contracts correspond to STEM areas.
20 December, 2024

The immune system is key in the development of mastocytosis

A study reveals how immunological alterations contribute to the development of this rare type of blood cancer, characterized by the accumulation of abnormal mast cells with a genetic mutation in various tissues and organs of the body.
19 December, 2024

Jesús de la Osada: “You have to enjoy your work every day and do it with the highest quality possible”

In this interview, the researcher from the IIS Aragón and the University of Zaragoza talks about his work leading the Group 'Molecular bases of atherosclerosis. Mediterranean diet and atherosclerosis' (GIIS009), and what his day-to-day work is like.
18 December, 2024

“ConoceRte” premieres, an innovative Aragonese podcast that addresses the challenges of youth mental health

Thanks to the coordination of the IIS Aragón, this project is part of the Research Group on Digital Communication and Information (GICID) of UNIZAR, in collaboration with ASAPME Aragón and sponsored by Johnson & Johnson, with the aim of making visible and normalizing the treatment of mental health in young people and adolescents.